Edwin Lisowski, Co-Founder and Chief Growth Officer of Addepto, oversees the company’s strategic growth, business development ...

CoLab today announced a $72M USD Series C fundraise, affirming its position as the company setting the pace in AI for engineering. The new funding comes on the heels of CoLab’s breakout launch of ...

Risk stratification of patients with chest pain has traditionally focused on identifying obstructive coronary artery disease (CAD). Using this traditional approach, many symptomatic individuals are ...

GIGABYTE's X870E AORUS X3D motherboards bring the latest technologies to the AM5 platform and add a healthy performance boost, too.

City Therapeutics, Inc., a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced the submission of a Clinical Trial Application (CTA) to the UK ...

The standard of care in cancer, adopted in the 1990s, is built on consensus based clinical research over large patient populations. However, if we know biologically each person is unique, then a ...